Home › Hologic, Inc. (HOLX) Upgraded at Zacks Investment Research
 

Keywords :   


Hologic, Inc. (HOLX) Upgraded at Zacks Investment Research

2015-12-21 05:46:43| Biotech - Topix.net

The firm currently has a $43.00 target price on the stock. Zacks Investment Research 's price target would indicate a potential upside of 11.46% from the company's previous close.

Tags: research investment upgraded zacks

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
06.10Hurricane Milton Public Advisory Number 5A
06.10Summary for Hurricane Milton (AT4/AL142024)
06.10Atlantic Tropical Weather Outlook
06.10Eastern North Pacific Tropical Weather Outlook
06.10Glatfelter Develops Biobased Espresso Lid Material
06.10Tropical Storm Milton Potential Storm Surge Flooding Map
06.10Tropical Storm Milton Probabilistic Storm Surge Graphics
06.10Firms urge mayor to rethink congestion charge plan
More »